Revenue growth reached 20.8% in 2026Q1, though operational headwinds caused NOI margins to contract to 61.4% from the 69.5% peak observed in 2023Q4.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|
| Revenue | 812.84M | 774.63M | 703.24M | 647.51M | 624.81M | 569.54M | 598.57M | 668.18M | 623.41M | 405.65M | 260.53M | 238.86M | 183.52M | 134.78M | 103.17M | 84.22M | 8.8M |
| Revenue Growth % | 12.89% | 10.15% | 8.61% | 3.63% | 9.7% | -4.85% | -10.42% | 7.18% | 53.68% | 55.7% | 9.07% | 30.16% | 36.16% | 30.64% | 22.49% | 857.1% | - |
| Property Operating Expenses | 296.81M | 271.11M | 227.09M | 195.25M | 162.61M | 141.2M | 131.55M | 109.71M | 49.55M | 17.86M | 5.7M | 2.58M | 3.91M | 0 | 0 | 0 | 0 |
| Net Operating Income (NOI) | 516.03M | 503.53M | 476.15M | 452.27M | 462.2M | 428.34M | 467.02M | 558.48M | 573.86M | 387.79M | 254.82M | 236.29M | 179.6M | 134.78M | 103.17M | 84.22M | 8.8M |
| NOI Margin % | 63.48% | 65% | 67.71% | 69.85% | 73.97% | 75.21% | 78.02% | 83.58% | 92.05% | 95.6% | 97.81% | 98.92% | 97.87% | 100% | 100% | 100% | 100% |
| Operating Expenses | 280.47M | 239.66M | 219.12M | 230.56M | 227.36M | 217.59M | 467.02M | 30.89M | 266.91M | 163.4M | 93.93M | 99.79M | 72.67M | 49.7M | 46.37M | 41.06M | 8.5M |
| G&A Expenses | 55.84M | 53.71M | 50.07M | 47.47M | 39.57M | 34.67M | 32.76M | 30.89M | 36.46M | 32.4M | 19.92M | 23.86M | 29.34M | 16.42M | 16.1M | 14.47M | 1.6M |
| EBITDA | 432.19M | 450.86M | 426.65M | 404.8M | 422.62M | 389.74M | 416.29M | 708.63M | 613.14M | 387.82M | 253.85M | 199.58M | 154.18M | 118.36M | 87.07M | 69.75M | 3.3M |
| EBITDA Margin % | 53.17% | 58.2% | 60.67% | 62.52% | 67.64% | 68.43% | 69.55% | 106.05% | 98.35% | 95.6% | 97.44% | 83.55% | 84.01% | 87.81% | 84.39% | 82.82% | 37.5% |
| Depreciation & Amortization | 196.63M | 187M | 169.62M | 183.09M | 187.78M | 178.99M | 176.74M | 181.04M | 306.19M | 163.43M | 92.96M | 63.08M | 43.33M | 33.28M | 30.26M | 26.59M | 3.1M |
| D&A / Revenue % | 24.19% | 24.14% | 24.12% | 28.28% | 30.05% | 31.43% | 29.53% | 27.09% | 49.11% | 40.29% | 35.68% | 26.41% | 23.61% | 24.69% | 29.33% | 31.57% | 35.23% |
| Operating Income | 235.56M | 263.87M | 257.03M | 221.71M | 234.84M | 210.75M | 0 | 527.59M | 306.95M | 224.39M | 160.89M | 136.5M | 110.85M | 85.08M | 56.8M | 43.16M | 200K |
| Operating Margin % | 28.98% | 34.06% | 36.55% | 34.24% | 37.59% | 37% | 0% | 78.96% | 49.24% | 55.32% | 61.76% | 57.15% | 60.4% | 63.12% | 55.06% | 51.24% | 2.27% |
| Interest Expense | 4M | 112.49M | 115.27M | 112.96M | 105.47M | 98.63M | 100.42M | 126.61M | 147.11M | 88.44M | 64.87M | 59.22M | 46.96M | 40.46M | 37.01M | 30.32M | 0 |
| Interest Coverage | - | 2.40x | 2.11x | 1.14x | 0.28x | -0.13x | 2.39x | 2.73x | 2.92x | 2.80x | 2.10x | 2.35x | 2.00x | 1.83x | 1.46x | 1.42x | - |
| Non-Operating Income | -5.94M | -5.97M | 14.04M | 92.99M | 205.73M | 223.53M | -239.55M | 181.55M | -122.92M | -14.93M | 27.01M | 4.92M | 16.98M | 10.9M | 2.96M | 0 | -3.91M |
| Pretax Income | 156.06M | 157.35M | 127.72M | 15.76M | -76.36M | -111.41M | 139.13M | 72.42M | 282.13M | 159.02M | 70.2M | 79.38M | 46.91M | 33.72M | 19.51M | 12.84M | 200K |
| Pretax Margin % | 19.2% | 20.31% | 18.16% | 2.43% | -12.22% | -19.56% | 23.24% | 10.84% | 45.26% | 39.2% | 26.95% | 33.23% | 25.56% | 25.01% | 18.91% | 15.25% | 2.27% |
| Income Tax | 1.95M | 1.84M | 1M | 2M | 1.24M | 1.84M | 710K | 3.4M | 3.01M | 651K | 75.48M | 61.45M | 0 | 0 | 39.2M | 0 | 242K |
| Effective Tax Rate % | 1.25% | 1.17% | 0.79% | 12.7% | -1.63% | -1.66% | 0.51% | 4.7% | 1.07% | 0.41% | 107.51% | 77.41% | 0% | 0% | 200.9% | 0% | 121% |
| Net Income | 156.19M | 155.61M | 126.71M | 13.76M | -77.61M | -113.26M | 138.42M | 69M | 279.08M | 158.38M | 70.28M | 79.41M | 46.95M | 33.72M | 19.51M | 12.84M | 7.38M |
| Net Margin % | 19.21% | 20.09% | 18.02% | 2.12% | -12.42% | -19.89% | 23.12% | 10.33% | 44.77% | 39.04% | 26.97% | 33.25% | 25.58% | 25.01% | 18.91% | 15.25% | 83.84% |
| Net Income Growth % | 10.96% | 22.81% | 821.14% | 117.73% | 31.48% | -181.82% | 100.62% | -75.28% | 76.21% | 125.37% | -11.51% | 69.14% | 39.26% | 72.78% | 51.95% | 74.06% | - |
| Funds From Operations (FFO) | 352.82M | 342.61M | 296.33M | 196.84M | 110.18M | 65.73M | 315.15M | 250.04M | 585.27M | 321.81M | 163.23M | 142.49M | 90.28M | 67M | 49.78M | 39.43M | 10.48M |
| FFO Margin % | 43.41% | 44.23% | 42.14% | 30.4% | 17.63% | 11.54% | 52.65% | 37.42% | 93.88% | 79.33% | 62.66% | 59.65% | 49.2% | 49.71% | 48.25% | 46.82% | 119.07% |
| FFO Growth % | 64.73% | 15.61% | 50.54% | 78.66% | 67.61% | -79.14% | 26.04% | -57.28% | 81.87% | 97.15% | 14.56% | 57.83% | 34.76% | 34.59% | 26.23% | 276.34% | - |
| FFO per Share | 1.38 | 1.40 | 1.26 | 0.85 | 0.48 | 0.30 | 1.52 | 1.33 | 3.27 | 3.04 | 2.49 | 2.28 | 1.93 | 1.76 | 1.33 | 1.31 | 0.42 |
| FFO Payout Ratio % | 61.82% | 84.5% | 94.54% | 140.95% | 251.56% | 399.97% | 88.31% | 134.15% | 55.57% | 56.58% | 73.06% | 77.13% | 90.26% | 86.8% | 98.3% | 80.24% | 0% |
| EPS (Diluted) | 0.61 | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 | 0.67 | 0.37 | 1.56 | 1.40 | 0.92 | 1.11 | 0.78 | 0.68 | 0.52 | 0.43 | 0.29 |
| EPS Growth % | 7.19% | 18.52% | 813.71% | 117.38% | 34.62% | -177.61% | 81.08% | -76.28% | 11.43% | 52.17% | -17.12% | 42.31% | 14.71% | 30.77% | 20.93% | 48.28% | - |
| EPS (Basic) | - | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 | 0.67 | 0.37 | 1.57 | 1.40 | 0.92 | 1.11 | 0.79 | 0.69 | 0.53 | 0.43 | 0.29 |
| Diluted Shares Outstanding | 255.97M | 244.5M | 236.05M | 232.79M | 230.95M | 219.07M | 207.25M | 188.13M | 178.72M | 105.84M | 65.52M | 62.46M | 46.89M | 38.07M | 37.32M | 30.17M | 25.2M |
Labor cost margin compression
According to the latest quarterly financial data, Sabra Health Care REIT achieved a 20.8% year-over-year revenue growth in 2026Q1, signaling a robust recovery in top-line performance that appears to be driven by a combination of inflationary rent escalators and improved occupancy within the managed portfolio segments.
The acceleration in revenue growth suggests that the company's strategic pivot toward high-acuity transitional care and behavioral health is beginning to yield tangible top-line results. However, investors should monitor whether this growth is sustainable or if it remains heavily reliant on one-time lease adjustments that may mask underlying volatility in the SHOP segment.
As reported in the company's income statement, the NOI margin contracted to 61.4% in 2026Q1 from a peak of 69.5% in 2023Q4, indicating that rising property-level operating expenses are increasingly offsetting the gains realized from the company's diversified revenue streams across its various healthcare facility asset classes.
The downward trend in NOI margins suggests that the integration of managed senior housing assets is introducing significant variable cost exposure, particularly regarding labor. This shift warrants further investigation into whether the company can effectively pass these rising costs through to tenants or if they will continue to act as a persistent drag on profitability.
Based on the provided financial figures, FFO per share reached $0.37 in 2026Q1, yet the historical data reveals significant quarterly fluctuations, including a notable 11.7% decline in 2025Q4, which suggests that the company's earnings quality remains sensitive to the inherent operational risks of its managed portfolio.
While the recent FFO growth appears positive, the inconsistency in quarterly performance may indicate that the company's earnings are susceptible to non-recurring items or timing differences in lease renewals. Analysts should remain cautious regarding the long-term safety of the dividend until the FFO trajectory demonstrates a more stable and predictable pattern.
Financial statements indicate that GAAP net income of $40.9M in 2026Q1 significantly understates the company's true economic performance, as substantial non-cash depreciation charges continue to obscure the actual cash-generating capacity of the underlying real estate assets held within the diverse healthcare portfolio.
The reliance on GAAP net income as a performance metric is misleading for this REIT, as it fails to account for the recurring maintenance CAPEX required to keep healthcare facilities competitive. Investors should prioritize FFO and AFFO metrics to better understand the true cash flow available for distribution and reinvestment.
Quick answers to the most common questions about buying SBRA stock.
For fiscal year 2025, Sabra Health Care REIT, Inc. (SBRA) reported total revenue of $774.6M. This represents a 8702.6% increase compared to $8.8M in 2010.
Sabra Health Care REIT, Inc. (SBRA) is profitable, generating $155.6M in net income for the fiscal year ending 2025 with a net profit margin of 20.1%.
Sabra Health Care REIT, Inc. (SBRA) reported an operating income of $263.9M, resulting in an operating profit margin of 34.1%. This margin reflects the operational efficiency of the business before interest and taxes.
Sabra Health Care REIT, Inc. (SBRA) generated $503.5M in gross profit for the year, representing a gross profit margin of 65.0%. This demonstrates the company's core pricing power and production efficiency.